- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06387043
Effects of Balance Exercises Performed With Different Visual Stimuli
April 24, 2024 updated by: Gülsena Utku, Halic University
Comparison of the Effects of Balance Exercises Performed With Different Visual Stimuli in Individuals With Multiple Sclerosis
The study aims to examine the effects of balance exercises applied with different visual stimuli on individuals with MS.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
The study aims to examine the effects of balance exercises applied with virtual reality glasses, stroboscopic glasses, and visual-based metaphor imaginary on individuals with MS, on their balance functions, coordination skills, and quality of life, and to compare these exercises with both traditional balance exercises, and compare each of them on motor learning, based on their effects on representational areas in the brain, and balance.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: GÜLSENA UTKU UMUT
- Phone Number: +905370664646
- Email: gulsenautkuumut@gmail.com
Study Contact Backup
- Name: ARZU RAZAK ÖZDİNÇLER
- Email: arzu.ozdincler@fbu.edu.tr
Study Locations
-
-
Eyüpsultan
-
Istanbul, Eyüpsultan, Turkey
- Halic University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ages of 18-50
- diagnosis of MS by a neurologist according to McDonald 2017 criteria (Carroll, 2018)
- Being between 2.5 and 4.5 on the Expanded Disability Status Scale (EDSS)
- Not having had an attack in the last 3 months
- Absence of spasticity severe enough to affect treatment (spasticity in any joint of the upper extremity and lower extremity is <2 according to the Modified Ashworth Scale)
- Getting ≥ 24 points from the Standardized Mini Mental Test (SMMT)
Exclusion Criteria:
- hearing or vision problems
- pregnancy
- Having changed medication in the last 3 months and using medication containing the active ingredient Fampridine
- Participating or participating in a regular physiotherapy and rehabilitation program in the last 3 months
- other accompanying neurological, orthopedic or vestibular disorders
- an upper or lower extremity contracture that prevents exercises
- History of epileptic seizure, migraine or vertigo attack in the last 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Balance Games with Virtual Reality Glasses
Individuals with MS in the first group will play balance games with virtual reality glasses for 15 minutes.
Three different progressive games will be determined according to the functional level of the individual.
Each game offers different gradually increasing difficulty levels and time options.
|
Balance exercises with Virtual Reality Glasses
|
|
Experimental: Balance Exercises with Stroboscopic Glasses
Individuals with MS in the second group will be given balance exercises with stroboscopic glasses for 15 minutes.
Exercises will be selected in accordance with the functional level of the individual and will progress according to the individual's condition.
In each session, 3-5 different exercises will be performed, taking into account the functional status of the individual.
|
Balance Exercises with Stroboscopic Glasses
|
|
Experimental: Balance Exercises with Visual-Based Metaphor Training
Individuals with MS in the third group will be given balance exercises simultaneously with metaphor training using various visuals for 15 minutes.
The images will be projected on the screen in front of the individuals and the individuals will be given the command: "Imagine the movement you are doing as in the image."
Meanwhile, reinforcers deemed necessary will be used by the researcher physiotherapist to increase the patient's participation and motivation.
Static balance exercises in the program will be performed first on stable surfaces and then on unstable surfaces.
In each session, 3-5 different exercises will be performed, taking into account the functional status of the individual.
The difficulty levels of the exercises will progress by adjusting according to the functional status of the individual.
|
Balance Exercises with Visual-Based Metaphor Training
|
|
Active Comparator: Traditional Balance Exercises
Individuals with MS in the fourth group will be given balance exercises for 15 minutes under the supervision of a researcher physiotherapist.
Exercises will be selected in accordance with the functional level of the individual and will progress according to the individual's condition.
In each session, 3-5 different exercises will be performed, taking into account the functional status of the individual.
|
Traditional Balance Exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Near Infrared Ray Spectroscopy (fNIRS)
Time Frame: Baseline and end of the 8th week
|
Functional near-infrared spectroscopy is a device used to evaluate brain functions in the cerebral cortex.
This device is an optical brain imaging method that measures the blood oxygenation level-dependent (BOLD) response of brain tissues.
With this method, relative changes in regional brain oxygenation in the part thought to be associated with brain activation can be determined.
In our study, Artinis Brite Lite® fNIRS systems will be used.
The system consists of a wearable soft head and has 10 channels.
In the evaluation procedure, a trial session will be conducted before the actual measurement, during which the subjects will be fitted with an fNIRS headset.
The balance tasks to be evaluated will consist of right and left weight transfer, standing with two feet together, standing on one leg, tandem walking, turning from right to left/left to right, jumping in place and jumping over obstacles (Sathe et al., 2023).
|
Baseline and end of the 8th week
|
|
Timed Up and Go Test
Time Frame: Baseline and end of the 8th week
|
It is an assessment tool with strong evidence for its validity as a measure of functional mobility in individuals with MS ( Sebastiao et al., 2016 ).
|
Baseline and end of the 8th week
|
|
Functional Reach Test
Time Frame: Baseline and end of the 8th week
|
It is an easily applicable dynamic balance measurement technique that has features similar to functional movements.
Distances below 15 cm have been found to be associated with an increased risk of falling (Weiner et al., 1992).
|
Baseline and end of the 8th week
|
|
Berg Balance Scale
Time Frame: Baseline and end of the 8th week
|
Berg Balance Scale is a scale that is widely used to evaluate balance disorders in multiple sclerosis patients (Berg et al., 1989), provides information about the patient's balance function, and is used to evaluate post-rehabilitation improvements (Gervasoni et al., 2016).
The scale consists of 14 items for monitoring performance.
Each item is scored between 0 and 4; A high score indicates good balance.
|
Baseline and end of the 8th week
|
|
Timed 25 Step Walking Test
Time Frame: Baseline and end of the 8th week
|
It will be used to evaluate the walking speed of individuals.
In Z25YT, which evaluates lower extremity function, patients are asked to walk a distance of 7.62 m as quickly as possible, but without running and safely, and the completion time is recorded in seconds.
|
Baseline and end of the 8th week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lower Extremity Motor Coordination Test
Time Frame: Baseline and end of the 8th week
|
This test was developed by Desrosiers et al. to evaluate the lower extremity motor coordination skills of patients with a history of stroke, low back pain and surgery.
Developed by.
The test begins with the individual sitting on a chair with the knees and ankles at a 90-degree angle.
Two red targets with a diameter of 6 cm are placed in front of it, distally and proximally, on a 55x50x0.4
cm mat, with 19 specific localization dimensions.
The individual is asked to touch the target closest to the big toe as quickly and smoothly as possible.
The number of movements made repetitively, smoothly and as fast as possible within 20 seconds is recorded (Desrosiers et al., 2005).
|
Baseline and end of the 8th week
|
|
Fatigue Severity Scale
Time Frame: Baseline and end of the 8th week
|
It is a scale consisting of 9 questions that evaluates fatigue.
Each item is scored between 0 and 7.
The total score is calculated by taking the arithmetic average of the scores.
A score <4 is interpreted as no fatigue, and a score ≥4 as fatigue (Whitehead, 2009).
The Turkish validity and reliability study of the scale was conducted by Armutlu et al., (Armutlu et al., 2007).
|
Baseline and end of the 8th week
|
|
Quality of Life in Multiple Sclerosis Patients
Time Frame: Baseline and end of the 8th week
|
Multiple Sclerosis Quality of Life Scale-54 was developed in 1995 by Vickrey et al.
It was developed by (Vickrey et al., 1995); Turkish validity and reliability study by İdiman et al.
Made by.
The scale examines individuals' health-related quality of life levels with Likert-type scoring in a total of 54 questions prepared specifically for MS disease.
Scoring varies between 0-100, with a higher score indicating a better quality of life (İdiman et al., 2006).
|
Baseline and end of the 8th week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: GÜLSENA UTKU UMUT, Halic University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2024
Primary Completion (Estimated)
March 1, 2025
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
April 18, 2024
First Submitted That Met QC Criteria
April 24, 2024
First Posted (Actual)
April 26, 2024
Study Record Updates
Last Update Posted (Actual)
April 26, 2024
Last Update Submitted That Met QC Criteria
April 24, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Multiple Sclerosis
- Sclerosis
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Neurotransmitter Uptake Inhibitors
- Membrane Transport Modulators
- Dopamine Agents
- Dopamine Uptake Inhibitors
- Central Nervous System Stimulants
- Sympathomimetics
- Adrenergic Uptake Inhibitors
- Methamphetamine
Other Study ID Numbers
- MS and Balance
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Balance exercises with Virtual Reality Glasses
-
Cairo UniversityCompletedCesarean Section ComplicationsEgypt
-
Badr UniversityActive, not recruiting
-
Marmara UniversityUnknownHealthy | Lower Extremity Problem | Coordination and Balance Disturbances
-
Universitat Jaume IUniversidad Complutense de Madrid; University of BarcelonaNot yet recruiting
-
Aydin Adnan Menderes UniversityActive, not recruitingOperation Time | Music Listening | UreteroscopyTurkey
-
Cihat OzyılmazCompletedChild | Anxiety | FearTurkey
-
Yuksek Ihtisas UniversityNot yet recruitingCoronary Angiography (CAG)Turkey
-
Yuzuncu Yil UniversityCompletedHyperthyroidism | Virtual RealityTurkey (Türkiye)
-
Ankara Yildirim Beyazıt UniversityCompletedVirtual Reality | Education | Bariatric Surgery | NursingTurkey (Türkiye)
-
Biruni UniversityCompleted